Target intelligence / Profile preview

Cell Killing

Molecular classification
Other
01

Overview

"Cell killing" refers to any process by which biological cells are actively eliminated, either via intrinsic genetic programs (such as apoptosis and autophagy) or through traumatic, pathological events (such as necrosis)[1][4][7]. While the phrase is commonly used in the context of immunology or oncology to indicate the destruction of target cells (e.g., cytotoxic T lymphocyte-mediated killing of tumor or infected cells), it does not designate a single, structurally defined molecule, protein, receptor, or gene product. Instead, it encompasses a spectrum of cell fates arising from diverse molecular pathways[1][4][5]. Key examples include apoptosis (programmed cell death driven by caspases and BCL-family proteins), necrosis (cell lysis due to acute damage), necroptosis (a programmed form of necrosis), autophagic cell death, and others[1][4][5][7]. Each mechanism involves its own canonical protein and gene targets, but "cell killing" itself is not a single drug target.\n\nThis entry is considered “incorrect” as a target name because it does not uniquely specify a defined molecule or actionable target suitable for drug discovery or structured biological curation—it is a functional outcome or phenotype, not a molecular entity.

Other names
Cell deathCell eliminationProgrammed cell deathApoptosisNecrosisAutophagic cell deathCell suicide
02

Biological functions

Cell deathTissue homeostasisRemoval of damaged or unwanted cellsEmbryonic developmentImmune responseResponse to injuryMaintenance of organismal health
03

Disease associations

CancerNeurodegenerative diseaseAutoimmune diseaseInfectionCardiovascular diseaseInflammationOther

Beyond the preview

Go deeper on Cell Killing.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cell Killing.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call